tiprankstipranks
Trending News
More News >
Biolife Sciences Inc. (BLFE)
:BLFE
US Market
Advertisement

Biolife Sciences (BLFE) Income Statement

Compare
56 Followers

Biolife Sciences Income Statement

Last quarter (Q3 2023), Biolife Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Biolife Sciences's net income was $0.00. See Biolife Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 411.69K$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -985.00K$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ 259.16K$ 0.00$ 42.28K
Depreciation and Amortization
$ 228.49K$ 236.56K$ 206.30K$ 171.86K$ 0.00
EBITDA
$ 0.00$ 0.00$ -1.24M$ 171.86K$ -42.28K
Operating Income
$ 0.00$ 0.00$ -1.24M$ 0.00$ -42.28K
Other Income/Expenses
$ 0.00$ 0.00$ -24.04K$ -1.13K$ -10.44K
Pretax Income
$ 0.00$ 0.00$ -1.27M$ -1.13K$ -52.72K
Net Income
$ 0.00$ 0.00$ -1.27M$ -1.13K$ -52.72K
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ -0.02$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ -0.02$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 0.00 51.78M 19.45M 19.45M
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 51.78M 19.45M 19.45M
Currency in USD

Biolife Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis